CH
Chemcrux Enterprises Ltd (CHEMCRUX)
₹77.63
Mkt cap
₹118 Cr
P/E ratio
26.40
P/B
1.49
Div yield
1.25%
ROE
3.01%
ROCE
6.43%
EPS (TTM)
₹2.94
Book value
₹52
52W range
72–93
Sector
Commodities
Price history
Previous close
Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates [1]
NSE CHEMCRUXBSE 540395
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−16.45% from high₹78
₹72+8.12% from low₹93
Current
₹77.63
Prev close
₹79.90
Day
−2.84%
Price performance
1D
−2.84%
1W
−6.15%
1M
−1.56%
3M
−10.38%
6M
—
1Y
—
YTD
−10.39%
Financials
Revenue, profit & margin
P/E ratio
26.4×
CHEMCRUX is 4% above the sector median of 25.4×
CHEMCRUX26.4×
Sector median25.4×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.84 | 21.81 | 18.54 | 17.11 | 17.76 | 19.42 | 15.72 | 16.50 | 17.75 | 22.11 | 24.28 | 21.94 | 23.84 | |
| YoY Sales growth | -7.35% | -23.24% | +12.12% | -10.96% | -15.21% | -3.57% | -0.06% | +13.85% | +54.45% | +32.97% | +34.31% | |||
| Expenses | 13.50 | 17.43 | 15.92 | 15.05 | 15.40 | 16.73 | 13.61 | 14.87 | 15.96 | 18.58 | 20.10 | 19.24 | 20.99 | |
| Operating Profit | 2.34 | 4.38 | 2.62 | 2.06 | 2.36 | 2.69 | 2.11 | 1.63 | 1.79 | 3.53 | 4.18 | 2.70 | 2.85 | |
| OPM % | 14.77% | 20.08% | 14.13% | 12.04% | 13.29% | 13.85% | 13.42% | 9.88% | 10.08% | 15.97% | 17.22% | 12.31% | 11.95% | |
| Other Income | 0.24 | 0.56 | 0.35 | 0.39 | 0.26 | 0.61 | 0.24 | 0.44 | 0.63 | 0.60 | 0.36 | 0.11 | 0.07 | |
| Interest | 0.21 | 0.17 | 0.13 | 0.13 | 0.33 | 0.60 | 0.69 | 0.86 | 0.83 | 0.76 | 0.70 | 0.64 | 0.62 | |
| Depreciation | 0.58 | 0.58 | 0.55 | 0.56 | 0.73 | 0.92 | 0.99 | 1.18 | 1.20 | 1.19 | 1.17 | 1.18 | 1.20 | |
| Profit before tax | 1.79 | 4.19 | 2.29 | 1.76 | 1.56 | 1.78 | 0.67 | 0.03 | 0.39 | 2.18 | 2.67 | 0.99 | 1.10 | |
| Tax % | 30.17% | 36.75% | 3.49% | 29.55% | 26.28% | 25.84% | 68.66% | -233.33% | 46.15% | 27.98% | 30.71% | 48.48% | 50.91% | |
| Net Profit | 1.24 | 2.66 | 2.21 | 1.24 | 1.15 | 1.32 | 0.21 | 0.09 | 0.21 | 1.58 | 1.85 | 0.51 | 0.55 | |
| EPS in Rs | 0.84 | 1.80 | 1.49 | 0.84 | 0.78 | 0.89 | 0.14 | 0.06 | 0.14 | 1.07 | 1.25 | 0.34 | 0.37 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202672.92%Promoter
Promoters72.92%
Public27.08%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | ₹1,580.50 | 59.98 | 1,60,980 | 0.73% | 626 | +6.09% | 4,298 | +20.91% | 31.02% |
| Gujarat Fluoroch | ₹4,978.60 | 80.23 | 54,690 | 0.06% | 240 | +35.75% | 1,760 | +45.45% | 9.64% |
| Navin Fluo.Intl. | ₹10,203.00 | 57.15 | 52,356 | 0.15% | 269 | +81.46% | 1,191 | +57.00% | 20.96% |
| Aether Industri. | ₹1,696.50 | 89.35 | 22,519 | 0.00% | 68 | +21.62% | 347 | +23.96% | 11.92% |
| Deepak Nitrite | ₹1,552.30 | 19.77 | 21,172 | 0.48% | 398 | +234.99% | 3,076 | +61.75% | 11.37% |
| Fine Organic | ₹5,457.00 | 34.74 | 16,731 | 0.20% | 152 | +40.14% | 729 | +22.12% | 21.47% |
| Aarti Industries | ₹456.85 | 27.33 | 16,572 | 0.22% | 168 | +100.00% | 3,669 | +74.71% | 6.86% |
| Chemcrux Enterp. | ₹79.90 | 26.35 | 118 | 1.25% | 1 | +161.90% | 24 | +34.31% | 6.43% |
| Median: 95 Co. | ₹322.00 | 25.41 | 848 | 0.27% | 11 | +36.39% | 172 | +28.92% | 14.16% |
Filings
Annual reports10
Announcements5
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 3 Nov - Chemcrux approved unaudited Q2/H1 FY2026-27 results on 2 Nov 2026; corrected review report filed on 3 Nov.Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Nov - Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th September 2026Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 2 Nov - Q2 FY27 standalone revenue ₹2,384.30 lakh; profit ₹162.42 lakh; board approved results on 2 Nov 2026.Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd November 2026 2 Nov - Board approved unaudited standalone and consolidated results for quarter and half year ended 30 September 2026.Board Meeting Intimation for Considering And Approving Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 For F.Y. 2026-27 And Other Related Matters Thereto And To Consider Any Other Business /Agenda 26 Oct - Board to meet on 2 November 2026 to approve Q2 and half-year FY27 unaudited results.






